Completed NA INTERVENTIONAL 2-arm NCT05556239

STAY-STRONG Study of Exercise Training During Chemotherapy (STAY-STRONG)

The Effect of Resistance Training in Patients With Malignant Lymphoma Undergoing Chemotherapy Treatment - the STAY STRONG TRIAL - a Randomized Controlled Trial.

Sponsor: Rigshospitalet, Denmark

Conditions Body Composition Exercise Lymphoma, B-Cell Lymphoma, Hodgkin Muscle, Skeletal Patient Reported Outcome Measures Physical Functional Performance Quality of Life Sarcopenia

Interventions Resistance Exercise Training

Updated 7 times since 2022 Last updated: Dec 1, 2025 Started: Oct 25, 2022 Primary completion: Oct 1, 2024 Completion: May 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05556239, this NA trial focuses on Body Composition and Exercise and remains completed. Sponsored by Rigshospitalet, Denmark, it has been updated 7 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed NA

Status: Active Not Recruiting → Completed
May 2025 — Jan 2026 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2023 — Jul 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Nov 2022 — May 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Nov 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark